Moussalli M, Pipe S W, Hauri H P, Nichols W C, Ginsburg D, Kaufman R J
Howard Hughes Medical Institute, University of Michigan School of Medicine, Ann Arbor, Michigan 48109, USA.
J Biol Chem. 1999 Nov 12;274(46):32539-42. doi: 10.1074/jbc.274.46.32539.
The endoplasmic reticulum-Golgi intermediate compartment (ERGIC) is the site of segregation of secretory proteins for anterograde transport, via packaging into COPII-coated transport vesicles. ERGIC-53 is a homo-hexameric transmembrane lectin localized to the ERGIC that exhibits mannose-selective properties in vitro. Null mutations in ERGIC-53 were recently shown to be responsible for the autosomal recessive bleeding disorder, combined deficiency of coagulation factors V and VIII. We have studied the effect of defective ER to Golgi cycling by ERGIC-53 on the secretion of factors V and VIII. The secretion efficiency of factor V and factor VIII was studied in a tetracycline-inducible HeLa cell line overexpressing a wild-type ERGIC-53 or a cytosolic tail mutant of ERGIC-53 (KKAA) that is unable to exit the ER due to mutation of two COOH-terminal phenylalanine residues to alanines. The results show that efficient trafficking of factors V and VIII requires a functional ERGIC-53 cycling pathway and that this trafficking is dependent on post-translational modification of a specific cluster of asparagine (N)-linked oligosaccharides to a fully glucose-trimmed, mannose9 structure.
内质网-高尔基体中间区室(ERGIC)是分泌蛋白通过包装进COPII包被的运输囊泡进行顺行运输的分选位点。ERGIC-53是一种定位于ERGIC的同型六聚体跨膜凝集素,在体外表现出对甘露糖的选择性特性。最近发现,ERGIC-53的无效突变是常染色体隐性出血性疾病、凝血因子V和VIII联合缺乏的病因。我们研究了ERGIC-53介导的从内质网到高尔基体循环缺陷对因子V和VIII分泌的影响。在四环素诱导的HeLa细胞系中,研究了野生型ERGIC-53或ERGIC-53胞质尾突变体(KKAA)对因子V和因子VIII分泌效率的影响。由于两个COOH末端苯丙氨酸残基突变为丙氨酸,该突变体无法离开内质网。结果表明,因子V和VIII的有效运输需要功能性的ERGIC-53循环途径,并且这种运输依赖于特定天冬酰胺(N)-连接寡糖簇的翻译后修饰,使其成为完全葡萄糖修剪的甘露糖9结构。